Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

FDA recall notice · announced September 28, 2016 · Genzyme Corporation / Genzyme Biosurgery

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp. Date

Notes

Distribution: nationwide
Lot/code information: Lot # 5RZ002; Exp. 04/18
Quantity: 9,530 vials
Status: Terminated
Products in this recall event:
- Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Compan (D-1518-2016)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.